{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:28:33Z","timestamp":1788582513409,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s10557-015-6600-y","type":"journal-article","created":{"date-parts":[[2015,6,13]],"date-time":"2015-06-13T01:54:43Z","timestamp":1434160483000},"page":"277-285","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["\u03b2-blocker Therapy is Not Associated with Reductions in Angina or Cardiovascular Events After Coronary Artery Bypass Graft Surgery: Insights from the IMAGINE Trial"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4419-8285","authenticated-orcid":false,"given":"Harmen G.","family":"Booij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Damman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Wayne","family":"Warnica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean L.","family":"Rouleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiek H.","family":"van Gilst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Daan","family":"Westenbrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,14]]},"reference":[{"key":"6600_CR1","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht310.P4876","volume":"34","author":"G Montalescot","year":"2013","unstructured":"Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34:2949\u20133003.","journal-title":"Eur Heart J"},{"key":"6600_CR2","doi-asserted-by":"crossref","unstructured":"Belsey J, Savelieva I, Mugelli A, et al. Relative efficacy of antianginal drugs used as add-on therapy in patients with stable angina: a systematic review and meta-analysis. Eur J Prev Cardiol. 2014.","DOI":"10.1177\/2047487314533217"},{"key":"6600_CR3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/CIRCULATIONAHA.106.685073","volume":"117","author":"JL Rouleau","year":"2008","unstructured":"Rouleau JL, Warnica WJ, Baillot R, et al. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery. Circulation. 2008;117:24\u201331.","journal-title":"Circulation"},{"key":"6600_CR4","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1136\/heartjnl-2011-300118","volume":"97","author":"BD Westenbrink","year":"2011","unstructured":"Westenbrink BD, Kleijn L, de Boer RA, et al. Sustained postoperative anaemia is associated with an impaired outcome after coronary artery bypass graft surgery: insights from the IMAGINE trial. Heart. 2011;97:1590\u20136.","journal-title":"Heart"},{"key":"6600_CR5","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jama.2012.12559","volume":"308","author":"S Bangalore","year":"2012","unstructured":"Bangalore S, Steg G, Deedwania P, et al. Beta-blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA. 2012;308:1340\u20139.","journal-title":"JAMA"},{"key":"6600_CR6","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","volume":"33","author":"J Perk","year":"2012","unstructured":"Perk J, De Backer G, Gohlke H, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J. 2012;33:1635\u2013701.","journal-title":"Eur Heart J"},{"key":"6600_CR7","first-page":"1191","volume":"18","author":"JW Warnica","year":"2002","unstructured":"Warnica JW, Gilst WH, Baillot R, et al. Ischemia management with Accupril post bypass Graft via Inhibition of angiotensin coNverting enzyme (IMAGINE): a multicentre randomized trial - design and rationale. Can J Cardiol. 2002;18:1191\u2013200.","journal-title":"Can J Cardiol"},{"key":"6600_CR8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/heartjnl-2013-304262","volume":"100","author":"S Bouri","year":"2014","unstructured":"Bouri S, Shun-Shin MJ, Cole GD, et al. Meta-analysis of secure randomised controlled trials of beta-blockade to prevent perioperative death in non-cardiac surgery. Heart. 2014;100:456\u201364.","journal-title":"Heart"},{"key":"6600_CR9","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1001\/jamainternmed.2014.2356","volume":"174","author":"W Brinkman","year":"2014","unstructured":"Brinkman W, Herbert MA, O\u2019Brien S, et al. Preoperative beta-blocker use in coronary artery bypass grafting surgery: national database analysis. JAMA Intern Med. 2014;174:1320\u20137.","journal-title":"JAMA Intern Med"},{"key":"6600_CR10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0735-1097(92)90499-D","volume":"19","author":"DT Kawanishi","year":"1992","unstructured":"Kawanishi DT, Reid CL, Morrison EC, et al. Response of angina and ischemia to long-term treatment in patients with chronic stable angina: a double-blind randomized individualized dosing trial of nifedipine, propranolol and their combination. J Am Coll Cardiol. 1992;19:409\u201317.","journal-title":"J Am Coll Cardiol"},{"key":"6600_CR11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/hrt.74.3.235","volume":"74","author":"H Sjoland","year":"1995","unstructured":"Sjoland H, Caidahl K, Lurje L, et al. Metoprolol treatment for two years after coronary bypass grafting: effects on exercise capacity and signs of myocardial ischaemia. Br Heart J. 1995;74:235\u201341.","journal-title":"Br Heart J"},{"key":"6600_CR12","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/CIRCULATIONAHA.112.120402","volume":"126","author":"VL Murthy","year":"2012","unstructured":"Murthy VL, Naya M, Foster CR, et al. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation. 2012;126:1858\u201368.","journal-title":"Circulation"},{"key":"6600_CR13","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa1406430","volume":"371","author":"K Fox","year":"2014","unstructured":"Fox K, Ford I, Steg PG, et al. Ivabradine in stable coronary artery disease without clinical heart failure. N Engl J Med. 2014;371:1091\u20139.","journal-title":"N Engl J Med"},{"key":"6600_CR14","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.amjcard.2010.06.048","volume":"106","author":"N Ozasa","year":"2010","unstructured":"Ozasa N, Kimura T, Morimoto T, et al. Lack of effect of oral beta-blocker therapy at discharge on long-term clinical outcomes of ST-segment elevation acute myocardial infarction after primary percutaneous coronary intervention. Am J Cardiol. 2010;106:1225\u201333.","journal-title":"Am J Cardiol"},{"key":"6600_CR15","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/jama.2014.3315","volume":"311","author":"CP Lexis","year":"2014","unstructured":"Lexis CP, van der Horst IC, Lipsic E, et al. Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial. JAMA. 2014;311:1526\u201335.","journal-title":"JAMA"},{"key":"6600_CR16","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/jamainternmed.2013.11349","volume":"174","author":"C Andersson","year":"2014","unstructured":"Andersson C, Merie C, Jorgensen M, et al. Association of beta-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study. JAMA Intern Med. 2014;174:336\u201344.","journal-title":"JAMA Intern Med"},{"key":"6600_CR17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jacc.2014.04.042","volume":"64","author":"C Andersson","year":"2014","unstructured":"Andersson C, Shilane D, Go AS, et al. Beta-blocker therapy and cardiac events among patients with newly diagnosed coronary heart disease. J Am Coll Cardiol. 2014;64:247\u201352.","journal-title":"J Am Coll Cardiol"},{"key":"6600_CR18","doi-asserted-by":"crossref","unstructured":"Campo G, Pavasini R, Malagu M, et al. Chronic obstructive pulmonary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical management. Cardiovasc Drugs Ther. 2015.","DOI":"10.1007\/s10557-014-6569-y"},{"key":"6600_CR19","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2012.07.013","volume":"60","author":"SD Fihn","year":"2012","unstructured":"Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012;60:e44\u2013164.","journal-title":"J Am Coll Cardiol"},{"key":"6600_CR20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10557-013-6448-y","volume":"27","author":"NL Groot de","year":"2013","unstructured":"de Groot NL, van Haalen HG, Spiegel BM, et al. Gastroprotection in low-dose aspirin users for primary and secondary prevention of ACS: results of a cost-effectiveness analysis including compliance. Cardiovasc Drugs Ther. 2013;27:341\u201357.","journal-title":"Cardiovasc Drugs Ther"},{"key":"6600_CR21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10557-013-6470-0","volume":"27","author":"ML Fokkema","year":"2013","unstructured":"Fokkema ML, Kleijn L, van der Meer P, et al. Long term effects of epoetin alfa in patients with ST- elevation myocardial infarction. Cardiovasc Drugs Ther. 2013;27:433\u20139.","journal-title":"Cardiovasc Drugs Ther"},{"key":"6600_CR22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10557-012-6424-y","volume":"27","author":"TG Lueder von","year":"2013","unstructured":"von Lueder TG, Krum H. RAAS inhibitors and cardiovascular protection in large scale trials. Cardiovasc Drugs Ther. 2013;27:171\u20139.","journal-title":"Cardiovasc Drugs Ther"},{"key":"6600_CR23","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1093\/eurheartj\/ehu056","volume":"35","author":"TF L\u00fcscher","year":"2014","unstructured":"L\u00fcscher TF, Gersh B, Landmesser U, et al. Is the panic about beta-blockersin peri-operative care justified? Eur Heart J. 2014;35:2442\u20134.","journal-title":"Eur Heart J"},{"key":"6600_CR24","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1093\/eurheartj\/ehu282","volume":"35","author":"SD Kristensen","year":"2014","unstructured":"Kristensen SD, Knuuti J, Saraste A, et al. 2014 ESC\/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: the joint task force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014;35:2383\u2013431.","journal-title":"Eur Heart J"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-015-6600-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-015-6600-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-015-6600-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T17:53:36Z","timestamp":1566842016000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-015-6600-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["6600"],"URL":"https:\/\/doi.org\/10.1007\/s10557-015-6600-y","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}